MiNK Therapeutics
INKT
INKT
29 hedge funds and large institutions have $848K invested in MiNK Therapeutics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.5K | |
| 2 | +$10.5K | |
| 3 | +$7.11K | |
| 4 |
Goldman Sachs
New York
|
+$1.83K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$484 |
Top Sellers
| 1 | -$27.1K | |
| 2 | -$18.9K | |
| 3 | -$17.6K | |
| 4 |
Millennium Management
New York
|
-$6.63K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |